この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1994/8/41 分で読めます
Glaxo, Inc., et al.; Withdrawal of Approval of 13 Abbreviated Antibiotic Applications and 2 Abbreviated New Drug Applications
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is withdrawing approval of 13 abbreviated antibiotic applications (AADA's) and 2 abbreviated new drug applications (ANDA's). The holders of the applications notified the agency in writing that the drug products were no being longer marketed and requested that the approval of the applications be withdrawn.
情報源の原言語: Federal Register — Health and Human Services原文の発表を開く →